Bristol Myers Squibb gets EC nod for expanded use of Breyanzi
https://seekingalpha.com/news/4420725-bristol-myers-squibb-gets-ec-nod-for-expanded-use-of-breyanzi?source=feed_sector_healthcare
Mar 14, 2025 -
0
Regeneron's Bispecific Antibody Obtains EC Nod for Lymphoma
https://www.zacks.com/stock/news/2327848/regeneron-s-bispecific-antibody-obtains-ec-nod-for-lymphoma?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2327848
Aug 27, 2024 - REGN's oncology portfolio gets a boost with the approval of odronextamab for treating follicular lymphoma and diffuse large B-cell lymphoma (DLBCL).
0
Ecopetrol S.A. (EC) Q2 2024 Earnings Call Transcript
https://seekingalpha.com/article/4715380-ecopetrol-s-ec-q2-2024-earnings-call-transcript?source=feed_sector_transcripts
Aug 17, 2024 - Ecopetrol S.A. (NYSE:NYSE:EC) Q2 2024 Earnings Conference Call August 14, 2024 10:00 AM ETCompany ParticipantsRicardo Roa - Chief Executive OfficerRafael...
0